MITCHELL KERNER: Open Payments
NPI 1356975940 · WILLIAMSVILLE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,725 in 161 payments from 21 companies in 2025. Trend: 2023 $2,892 · 2024 $2,549 · 2025 $3,725
Food & beverage: $3,626Education: $99
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 24 | $639 |
| GlaxoSmithKline, LLC. | 31 | $581 |
| GENZYME CORPORATION | 17 | $372 |
| Merck Sharp & Dohme LLC | 8 | $268 |
| Inspire Medical Systems, Inc. | 7 | $235 |
| Regeneron Healthcare Solutions, Inc. | 10 | $229 |
| Verona Pharma, Inc. | 16 | $221 |
| Mallinckrodt Hospital Products Inc. | 7 | $194 |
| Grifols USA, LLC | 9 | $155 |
| Actelion Pharmaceuticals US, Inc. | 2 | $130 |
Products named: DUPIXENT, NUCALA, FASENRA, TRELEGY ELLIPTA, INSPIRE, Ohtuvayre, WINREVAIR, ACTHAR.
Industry payments across NY — which companies pay providers there.
